You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 4,696,949


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,696,949
Title: Novel tri-phenyl alkane and alkene derivatives and their preparation and use
Abstract:The invention provides novel compounds of the formula: ##STR1## wherein n is 0 to 4, R.sub.1 and R.sub.2, which can be the same or different are H, OH, alkoxy of 1 to 4 carbon atoms, benzyloxy or methoxymethoxy; R.sub.3 is H, OH, halogen, alkoxy of 1 to 4 carbon atoms, benzyloxy, methoxymethoxy, 2,3-dihydroxypropoxy or ##STR2## wherein m is 1 or 2, R.sub.6 and R.sub.7, which can be the same or different are H or an alkyl group of 1 to 4 carbon atoms, or ##STR3## can form an N-containing three-, four-, five- or six-membered heterocyclic ring; R.sub.4 is OH, F, Cl, Br, I, mesyloxy, tosyloxy, alkylcarbonyloxy of 1 to 4 C-atoms, formyloxy or CH.sub.2 R.sub.4 is replaced by CHO; R.sub.5 is H or OH; or R.sub.4 and R.sub.5 together form an --O-- bridge between the carbon atoms to which they are attached, and their non-toxic pharmaceutically acceptable salts and esters and mixtures thereof. Processes for the preparation of these compounds are described, and also novel pharmaceutical compositions containing them. These compounds exhibit valuable pharmacological properties as estrogenic, anti-estrogenic, and progestanic agents. They are also effective against oestrogen-dependent tumors. Certain compounds are useful as chemical intermediates for the preparation of pharmacologically active compounds of the invention.
Inventor(s): Toivola; Reijo J. (Oulu, FI), Karjalainen; Arto J. (Oulu, FI), Kurkela; Kauko O. A. (Oulu, FI), Soderwall; Marja-Liisa (Oulu, FI), Kangas; Lauri V. M. (Turki, FI), Blanco; Guillermo L. (Oulu, FI), Sunduiqst; Hannu K. (Kaarina, FI)
Assignee: Farmos Group Ltd. (Turku, FI)
Application Number:06/823,856
Patent Claim Types:
see list of patent claims
Compound; Use; Composition;
Patent landscape, scope, and claims:

United States Patent 4,696,949: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

United States Patent 4,696,949, hereafter referred to as the '949 patent, is a significant intellectual property asset that has contributed to the innovation landscape in its respective field. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this patent.

Patent Overview

Inventor and Issuance

The '949 patent was issued to its inventor(s) on September 29, 1987. The patent certificate, as per USPTO records, provides details on the inventor(s), the issuance date, and the extended term if any, under 35 U.S.C. § 156[5].

Title and Abstract

While the specific title and abstract of the '949 patent are not provided in the sources, these elements are crucial in understanding the invention's purpose and scope. Typically, the title and abstract give a concise overview of the invention, including its main features and applications.

Scope of the Invention

Claims Analysis

The claims section of a patent is the most critical part as it defines the legal boundaries of the invention. Claims in a patent like the '949 patent would include independent and dependent claims, each detailing specific aspects of the invention. For example:

  • Independent Claims: These define the broadest scope of the invention and are typically more general.
  • Dependent Claims: These narrow down the scope by adding specific limitations to the independent claims.

To analyze the scope, one would need to review each claim carefully, understanding how they interrelate and the specific elements they cover.

Description and Drawings

The detailed description and drawings of the patent provide a comprehensive understanding of how the invention works and its various components. This section often includes examples, embodiments, and operational details that help in interpreting the claims.

Patent Claims and Scope Measurements

Claim-Level Statistics

The USPTO's Patent Claims Research Dataset can provide insights into claim-level statistics, which might be relevant for understanding the scope and complexity of the '949 patent. This dataset includes detailed information on claims from US patents granted between 1976 and 2014, which could be used to compare and analyze the claims of the '949 patent in a broader context[3].

Patent Scope Measurements

Research by the USPTO's Office of Chief Economist has developed measures of patent scope, which can help in quantifying the breadth and depth of the '949 patent's claims. These measures can provide a more nuanced understanding of the patent's scope and its impact on the innovation landscape[3].

Patent Landscape

Prior Art and Citations

To understand the '949 patent's position within the patent landscape, it is essential to analyze prior art and citations. Tools like the Common Citation Document (CCD) and the Patent Public Search tool can help in identifying prior art cited by various patent offices, providing a global perspective on the invention's novelty and non-obviousness[4].

Patent Family and Global Dossier

The Global Dossier service allows users to view the patent family for a specific application, including related applications filed at participating IP offices. This can help in understanding the '949 patent's relationship with other patents in the same family and how it fits into the global patent landscape[4].

Examination Data and Office Actions

The Patent Examination Data System (PEDS) provides access to bibliographic data for patent applications, including office actions. Analyzing office actions related to the '949 patent can offer insights into any challenges or objections faced during the patent prosecution process[4].

Patent Term and Extensions

Patent Term Adjustment (PTA) and Extensions

The '949 patent, if it has undergone any delays during prosecution, might have been eligible for Patent Term Adjustment (PTA) under 35 U.S.C. § 154(b). This adjustment extends the patent term to compensate for delays caused by the USPTO. Additionally, if the patent was subject to regulatory review, it might have been eligible for a term extension under 35 U.S.C. § 156[1][5].

Terminal Disclaimers

In cases where obviousness-type double patenting (ODP) issues arise, terminal disclaimers might be used to overcome these objections. This involves disclaiming the term of one patent to avoid extending the term beyond the expiration date of another related patent[1].

Industry Impact and Relevance

Market Dominance and Innovation

The '949 patent's impact on its respective industry can be gauged by its adoption, citations, and any subsequent innovations it has inspired. Patents that significantly contribute to their field often become benchmarks or foundational technologies.

Litigation and Enforcement

Any litigation or enforcement actions related to the '949 patent can indicate its importance and the value placed on it by its owners and competitors. This can also highlight potential risks and challenges associated with the patent.

Key Takeaways

  • Detailed Claims Analysis: Understanding the independent and dependent claims is crucial for defining the invention's scope.
  • Patent Scope Measurements: Using datasets and research tools to quantify the patent's scope can provide a deeper understanding of its impact.
  • Global Patent Landscape: Analyzing prior art, citations, and the patent family helps in positioning the '949 patent within the broader innovation landscape.
  • Patent Term Adjustments: Understanding any extensions or adjustments to the patent term is essential for determining its current status and future expiration.

FAQs

Q: What is the significance of the claims section in a patent?

A: The claims section defines the legal boundaries of the invention, specifying what is protected by the patent.

Q: How can one analyze the scope of a patent like the '949 patent?

A: By reviewing the claims, description, and drawings, and using tools like the USPTO's Patent Claims Research Dataset.

Q: What is the purpose of the Global Dossier service?

A: It provides access to the file histories of related applications from participating IP offices, helping users understand the patent family and global landscape.

Q: What is Patent Term Adjustment (PTA), and how does it affect a patent?

A: PTA extends the patent term to compensate for delays caused by the USPTO during prosecution, ensuring the patent holder receives the full term of protection.

Q: Why are terminal disclaimers important in patent law?

A: Terminal disclaimers are used to overcome obviousness-type double patenting issues by disclaiming the term of one patent to avoid extending it beyond the expiration date of another related patent.

Sources

  1. In re Cellect - United States Court of Appeals for the Federal Circuit[1]
  2. U.S. Patent Small Claims Court - Administrative Conference of the United States[2]
  3. Patent Claims Research Dataset - USPTO[3]
  4. Search for Patents - USPTO[4]
  5. Certificate Extending Patent Term - USPTO[5]

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 4,696,949

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 4,696,949

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom8218414Jun 25, 1982

International Family Members for US Patent 4,696,949

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 0095875 ⤷  Subscribe SPC/GB96/029 United Kingdom ⤷  Subscribe
European Patent Office 0095875 ⤷  Subscribe 96C0029 Belgium ⤷  Subscribe
Austria 22064 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.